Bad time in biotech - Avis employé Sales Benchling

3,0
21 janv. 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Competitive OTE and provides a satisfying challenge.

Inconvénients

Biotech market is bad right now and only 1 or 2 salespersons are hitting quota so nobody is making close to their OTE. Constant turnover in leadership and lack of consistent direction

Découvrez plus d’avis sur Benchling

5,0
16 déc. 2025
Recommande
Approbation du PDG
Perspective commerciale

Avantages

1. Culture is great 2. Leadership is transparent 3. Business fundamentals are strong

Inconvénients

1. Growing pains from being a mid stage company 2. Founders lack experience (but mitigate it well)

1
4,0
9 mars 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

The leader in the R&D software industry

Inconvénients

Lots of change in the sales org in the past year - previously unclear in its mission

Voir les avis par: Utile|Évaluation|Date|Tout